November 28, 2015
Recommended Topic Related To:


"The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-ap"...


How Supplied


FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.


The dosage of FARESTON is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.


Dosage Forms And Strengths

Tablet is 60 mg, round, convex, unscored, uncoated, and white, or almost white, identified with TO 60 embossed on one side.

Storage And Handling

FARESTON Tablets, containing toremifene citrate in an amount equivalent to 60 mg of toremifene, are round, convex, unscored, uncoated, and white, or almost white.

FARESTON Tablets are identified with TO 60 embossed on one side.

FARESTON Tablets are available as:

NDC 11399-005-30 bottles of 30
11399-005-01 bottles of 100
11399-005-07 samples of 7

Store at 25°C (77°F).

Excursions permitted to 15-30°C (59-86°F)

[See USP Controlled Room Temperature.]

Protect from heat and light.

Distributed by GTx, Inc. Memphis, TN 38103, USA. Rev. 03/2011

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 6/3/2011

How Supplied

Fareston - User Reviews

Fareston User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Fareston sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Breast Cancer

Find support and advances in treatment.